Published: 02-06-2022 15:40 | Updated: 02-06-2022 17:13

Blocking calcium pump inhibitor may help stop hearts from failing

In a collaboration between researchers from AstraZeneca and Karolinska Institutet a study about potential new treatments for heart failure is now published in Nature Communications.

Read the full news article on AstraZeneca written by Erwin De Genst, Senior Research Scientist, Biologics Engineering, R&D, AstraZeneca and Kylie Foo, Assistant Professor, Karolinska Institutet


Blocking phospholamban with VHH intrabodies enhances contractility and relaxation in heart failure.
De Genst E, Foo KS, Xiao Y, Rohner E, de Vries E, Sohlmér J, Witman N, Hidalgo A, Kolstad TRS, Louch WE, Pehrsson S, Park A, Ikeda Y, Li X, Mayr LM, Wickson K, Jennbacken K, Hansson K, Fritsche-Danielson R, Hunt J, Chien KR
Nat Commun 2022 May;13(1):3018


Kylie Foo Thams Affiliated to Research